Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021 — Data Talk

Vertex Pharmaceuticals Incorporated (VRTX) is currently at $474.81, down $1.50 or 0.31%


--Would be lowest close since June 23, 2026, when it closed at $468.42

--On pace for largest percent decrease since July 14, 2026, when it fell 0.82%

--Currently down seven consecutive days; down 10.34% over this period

--Longest losing streak since Aug. 16, 2021, when it fell for seven straight trading days

--Worst seven day stretch since the seven days ending Aug. 13, 2025, when it fell 16.17%

--Down 4.41% month-to-date

--Up 4.73% year-to-date

--Down 10.34% from its all-time closing high of $529.59 on July 6, 2026

--Up 1.12% from 52 weeks ago (July 16, 2025), when it closed at $469.55

--Down 10.34% from its 52-week closing high of $529.59 on July 6, 2026

--Up 29.54% from its 52-week closing low of $366.54 on Aug. 8, 2025

--Traded as low as $469.60; lowest intraday level since June 23, 2026, when it hit $463.76

--Down 1.41% at today's intraday low

--10th least active stock in the Nasdaq 100 today


All data as of 10:45:14 AM ET


Source: Dow Jones Market Data, FactSet


(END) Dow Jones Newswires

July 15, 2026 11:02 ET (15:02 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center